Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Vistagen Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 48 | −7 |
| Shares | 14.7M | 582 | 11.8M | −2.95M (−20.1%) |
| Value | $8.12M | $333 | $2.54M | −$5.58M (−68.7%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commodore Capital LP | 2,788,620 | $630.2K | 0.04% |
| Citadel Advisors LLC | 68,839 | $15.6K | 0.00% |
| Virtu Financial LLC | 66,021 | $15.0K | 0.00% |
| Confluence Wealth Services, Inc. | 32,610 | $7.37K | 0.00% |
| Scientech Research LLC | 30,283 | $6.84K | 0.01% |
| R Squared Ltd | 27,745 | $6.27K | 0.00% |
| Bank of America Corp | 16,570 | $3.75K | 0.00% |
| Farther Finance Advisors, LLC | 15,000 | $3.39K | 0.00% |
| Deutsche Bank AG | 12,000 | $2.76K | 0.00% |
Sold out (16)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| OrbiMed Advisors LLC | 3,060,000 | $1.75M |
| TCG Crossover Management, LLC | 2,676,580 | $1.53M |
| Millennium Management LLC | 430,404 | $246.0K |
| Shay Capital LLC | 144,452 | $82.6K |
| Susquehanna International Group, LLP | 142,607 | $81.5K |
| Tudor Investment Corp Et Al | 106,172 | $60.7K |
| Diadema Partners LP | 105,428 | $60.3K |
| Prudential Financial Inc | 53,100 | $30.3K |
| Persistent Asset Partners Ltd | 26,612 | $15.2K |
| Schonfeld Strategic Advisors LLC | 26,589 | $15.2K |
| HRT Financial LP | 25,370 | $14.0K |
| Two Sigma Securities, LLC | 16,495 | $9.43K |
| Caption Management, LLC | 14,664 | $8.38K |
| Annis Gardner Whiting Capital Advisors, LLC | 600 | $343 |
| MAI Capital Management | 526 | $301 |
| Northwestern Mutual Wealth Management Co | 16 | $9 |
Not filed for Q2 2026 yet (1)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 582 | $333 |